Marcus Cantillon
Chief Tech/Sci/R&D Officer bij Reviva Pharmaceuticals, Inc.
Vermogen: 59 422 $ op 31-03-2024
Profiel
Marcus Cantillon is currently the Chief Medical Officer at Reviva Pharmaceuticals, Inc. He previously worked as a Senior Director at AstraZeneca PLC from 1995 to 1997, as well as a Senior Director-Global Clinical Research at MPX Bioceutical ULC.
From 2006 to 2010, he was an Assistant Vice President at Merck & Co., Inc. He also served as the Chief Medical Officer at Reviva Pharmaceuticals Holdings, Inc. from 2020 to 2022.
Cantillon holds a doctorate degree from Karolinska Institutet.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-09-2023 | 15 720 ( 0.06% ) | 59 422 $ | 31-03-2024 |
Actieve functies van Marcus Cantillon
| Bedrijven | Functie | Begin |
|---|---|---|
Reviva Pharmaceuticals, Inc.
 Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Chief Tech/Sci/R&D Officer | 01-01-2013 |
Eerdere bekende functies van Marcus Cantillon
| Bedrijven | Functie | Einde |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 05-07-2022 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-01-2010 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-1997 |
| MPX BIOCEUTICAL CORP | Chief Tech/Sci/R&D Officer | - |
Opleiding van Marcus Cantillon
| Karolinska Institutet | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
MPX Bioceutical ULC
 MPX Bioceutical ULC Pharmaceuticals: MajorHealth Technology MPX Bioceutical Corp. engages in the provision of management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services. It offers financial and business assistance to emerging corporations, which includes pharmaceutical, medical and biotechnology industries. The company was founded on April 2, 1974 and is headquartered in Toronto, Canada. | Health Technology |
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reviva Pharmaceuticals, Inc. operates as a clinical stage development pharmaceutical company. The firm develops various therapies using chemical genomics for treatment of central nervous system, cardiovascular, metabolic and inflammatory diseases. The company was founded by Laxminarayan Bhat in 2006 and is headquartered in Cupertino, CA. | Health Technology |
| Reviva Pharmaceuticals Holdings, Inc. |
